John Fromhold, chief executive officer at Hackensack Meridian Mountainside Medical Center, on Jan. 14 announced his retirement effective May 1, 2020.
Fromhold has held the post for 12 years. Tim O’Brien, chief operating officer, will serve as interim CEO during the board’s search for a permanent replacement.
“It was important to me that I begin this new chapter in my life with the completion and occupancy of our new medical office building,” said Fromhold.
The new building officially opened last week with 45,375 square feet of professional office space for health care providers, including obstetrics and gynecology, internal medicine, family medicine, urology, general surgery, cardiology, orthopedics, ENT, pulmonary, GI, endocrinology, plastic surgery and neurosurgery.
In 2007, Fromhold identified the Montclair hospital as an acquisition candidate while he was a partner and senior vice president at Merit Health Systems, a private company based in Louisville, Ky. When a joint venture between Ardent Health Services and Hackensack Meridian acquired the facility, Fromhold accepted the CEO role, overseeing the hospital’s revitalization and transformation. During his tenure, he focused on maximizing the benefits of the hospital’s joint venture ownership.
“I’ve been working with John since 2011. He was instrumental in helping us achieve our mission to transform health care. Under his great leadership, the hospital turned around and ultimately thrived. We are proud to have Mountainside Medical Center as part of our network providing high quality, convenient and affordable health care to the communities we serve. I wish John and his family the very best in his retirement,” said Robert Garrett, CEO of Hackensack Meridian Health.
Fromhold’s recent achievements include the hospital’s successful transition in 2019 to Epic, considered the gold standard among electronic health records systems. He was also instrumental in securing an agreement with Hackensack University Medical Center to pave the way for Mountainside to become a future satellite of the John Theurer Cancer Center (NCI designated), offering enhanced oncology services to the community.
In addition, because of the recent expansion of its neurosciences program, Mountainside will seek Joint Commission certification as a Thrombectomy-Capable Stroke Center in 2020. The hospital will also convert the sixth floor to a skilled nursing facility for patients requiring more medical services than can be delivered in a home setting.